Status:
COMPLETED
A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver Disease
Lead Sponsor:
Ma Zhe
Conditions:
Fatty Liver Disease
Eligibility:
All Genders
18-65 years
Brief Summary
Aims: To evaluate the diagnostic performance of ultrasound-derived fat fraction (UDFF) in assessing the degree of hepatic steatosis in an obese population, with liver biopsy as reference standard. Ma...
Eligibility Criteria
Inclusion
- BMI over 30 kg/m²
- diffuse fatty liver or inhomogeneous fatty liver diagnosed by conventional B-mode ultrasound
- serologic test results were available
Exclusion
- patients who have undergone liver resection or have liver space-occupying lesions
- pregnant women
- patients with incomplete medical history data
Key Trial Info
Start Date :
April 29 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06487325
Start Date
April 29 2023
End Date
May 1 2024
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QianfoshanH
Jinan, Shandong, China, 250014